Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials.
about
Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.Emerging treatment options for BRAF-mutant colorectal cancer.BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report.Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.Combination drug development in BRAF mutant colorectal cancer.
P2860
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Investigating the poor outcome ...... in randomised clinical trials.
@en
Investigating the poor outcome ...... in randomised clinical trials.
@en-gb
Investigating the poor outcome ...... in randomised clinical trials.
@nl
type
label
Investigating the poor outcome ...... in randomised clinical trials.
@en
Investigating the poor outcome ...... in randomised clinical trials.
@en-gb
Investigating the poor outcome ...... in randomised clinical trials.
@nl
prefLabel
Investigating the poor outcome ...... in randomised clinical trials.
@en
Investigating the poor outcome ...... in randomised clinical trials.
@en-gb
Investigating the poor outcome ...... in randomised clinical trials.
@nl
P2093
P50
P356
P1154
2-s2.0-85018261805
P1433
P1476
Investigating the poor outcome ...... in randomised clinical trials.
@en
P2093
J F Seligmann
S D Richman
P304
P356
10.1093/ANNONC/MDW645
P5530
P577
2016-12-19T00:00:00Z
P6179
1059394946